Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gene-based Advanced Therapy Medical Product Market Growth (Status and Outlook) 2022-2028

  • LP 4891119
  • 102 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gene-based Advanced Therapy Medical Product will have significant change from previous year. According to our (LP Information) latest study, the global Gene-based Advanced Therapy Medical Product market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gene-based Advanced Therapy Medical Product market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Gene-based Advanced Therapy Medical Product market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene-based Advanced Therapy Medical Product market, reaching US$ million by the year 2028. As for the Europe Gene-based Advanced Therapy Medical Product landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gene-based Advanced Therapy Medical Product players cover Biogen, Novartis, Gilead Sciences, and Sarepta Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Advanced Therapy Medical Product market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Viral Gene Delivery System

Non-viral Gene Delivery System

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Neurological Diseases

Cancer

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Human Stem Cells Institute

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gene-based Advanced Therapy Medical Product Market Size 2017-2028

2.1.2 Gene-based Advanced Therapy Medical Product Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gene-based Advanced Therapy Medical Product Segment by Type

2.2.1 Viral Gene Delivery System

2.2.2 Non-viral Gene Delivery System

2.3 Gene-based Advanced Therapy Medical Product Market Size by Type

2.3.1 Gene-based Advanced Therapy Medical Product Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

2.4 Gene-based Advanced Therapy Medical Product Segment by Application

2.4.1 Neurological Diseases

2.4.2 Cancer

2.4.3 Other

2.5 Gene-based Advanced Therapy Medical Product Market Size by Application

2.5.1 Gene-based Advanced Therapy Medical Product Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

3 Gene-based Advanced Therapy Medical Product Market Size by Player

3.1 Gene-based Advanced Therapy Medical Product Market Size Market Share by Players

3.1.1 Global Gene-based Advanced Therapy Medical Product Revenue by Players (2020-2022)

3.1.2 Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Players (2020-2022)

3.2 Global Gene-based Advanced Therapy Medical Product Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gene-based Advanced Therapy Medical Product by Regions

4.1 Gene-based Advanced Therapy Medical Product Market Size by Regions (2017-2022)

4.2 Americas Gene-based Advanced Therapy Medical Product Market Size Growth (2017-2022)

4.3 APAC Gene-based Advanced Therapy Medical Product Market Size Growth (2017-2022)

4.4 Europe Gene-based Advanced Therapy Medical Product Market Size Growth (2017-2022)

4.5 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gene-based Advanced Therapy Medical Product Market Size by Country (2017-2022)

5.2 Americas Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022)

5.3 Americas Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gene-based Advanced Therapy Medical Product Market Size by Region (2017-2022)

6.2 APAC Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022)

6.3 APAC Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gene-based Advanced Therapy Medical Product by Country (2017-2022)

7.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022)

7.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gene-based Advanced Therapy Medical Product by Region (2017-2022)

8.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022)

8.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gene-based Advanced Therapy Medical Product Market Forecast

10.1 Global Gene-based Advanced Therapy Medical Product Forecast by Regions (2023-2028)

10.1.1 Global Gene-based Advanced Therapy Medical Product Forecast by Regions (2023-2028)

10.1.2 Americas Gene-based Advanced Therapy Medical Product Forecast

10.1.3 APAC Gene-based Advanced Therapy Medical Product Forecast

10.1.4 Europe Gene-based Advanced Therapy Medical Product Forecast

10.1.5 Middle East & Africa Gene-based Advanced Therapy Medical Product Forecast

10.2 Americas Gene-based Advanced Therapy Medical Product Forecast by Country (2023-2028)

10.2.1 United States Gene-based Advanced Therapy Medical Product Market Forecast

10.2.2 Canada Gene-based Advanced Therapy Medical Product Market Forecast

10.2.3 Mexico Gene-based Advanced Therapy Medical Product Market Forecast

10.2.4 Brazil Gene-based Advanced Therapy Medical Product Market Forecast

10.3 APAC Gene-based Advanced Therapy Medical Product Forecast by Region (2023-2028)

10.3.1 China Gene-based Advanced Therapy Medical Product Market Forecast

10.3.2 Japan Gene-based Advanced Therapy Medical Product Market Forecast

10.3.3 Korea Gene-based Advanced Therapy Medical Product Market Forecast

10.3.4 Southeast Asia Gene-based Advanced Therapy Medical Product Market Forecast

10.3.5 India Gene-based Advanced Therapy Medical Product Market Forecast

10.3.6 Australia Gene-based Advanced Therapy Medical Product Market Forecast

10.4 Europe Gene-based Advanced Therapy Medical Product Forecast by Country (2023-2028)

10.4.1 Germany Gene-based Advanced Therapy Medical Product Market Forecast

10.4.2 France Gene-based Advanced Therapy Medical Product Market Forecast

10.4.3 UK Gene-based Advanced Therapy Medical Product Market Forecast

10.4.4 Italy Gene-based Advanced Therapy Medical Product Market Forecast

10.4.5 Russia Gene-based Advanced Therapy Medical Product Market Forecast

10.5 Middle East & Africa Gene-based Advanced Therapy Medical Product Forecast by Region (2023-2028)

10.5.1 Egypt Gene-based Advanced Therapy Medical Product Market Forecast

10.5.2 South Africa Gene-based Advanced Therapy Medical Product Market Forecast

10.5.3 Israel Gene-based Advanced Therapy Medical Product Market Forecast

10.5.4 Turkey Gene-based Advanced Therapy Medical Product Market Forecast

10.5.5 GCC Countries Gene-based Advanced Therapy Medical Product Market Forecast

10.6 Global Gene-based Advanced Therapy Medical Product Forecast by Type (2023-2028)

10.7 Global Gene-based Advanced Therapy Medical Product Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Biogen

11.1.1 Biogen Company Information

11.1.2 Biogen Gene-based Advanced Therapy Medical Product Product Offered

11.1.3 Biogen Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Biogen Main Business Overview

11.1.5 Biogen Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Gene-based Advanced Therapy Medical Product Product Offered

11.2.3 Novartis Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Information

11.3.2 Gilead Sciences Gene-based Advanced Therapy Medical Product Product Offered

11.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Gilead Sciences Main Business Overview

11.3.5 Gilead Sciences Latest Developments

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Information

11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sarepta Therapeutics Main Business Overview

11.4.5 Sarepta Therapeutics Latest Developments

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Information

11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product Offered

11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Alnylam Pharmaceuticals Main Business Overview

11.5.5 Alnylam Pharmaceuticals Latest Developments

11.6 Amgen

11.6.1 Amgen Company Information

11.6.2 Amgen Gene-based Advanced Therapy Medical Product Product Offered

11.6.3 Amgen Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Amgen Main Business Overview

11.6.5 Amgen Latest Developments

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Information

11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Spark Therapeutics Main Business Overview

11.7.5 Spark Therapeutics Latest Developments

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Information

11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Akcea Therapeutics Main Business Overview

11.8.5 Akcea Therapeutics Latest Developments

11.9 bluebird bio

11.9.1 bluebird bio Company Information

11.9.2 bluebird bio Gene-based Advanced Therapy Medical Product Product Offered

11.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 bluebird bio Main Business Overview

11.9.5 bluebird bio Latest Developments

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Information

11.10.2 Sunway Biotech Gene-based Advanced Therapy Medical Product Product Offered

11.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sunway Biotech Main Business Overview

11.10.5 Sunway Biotech Latest Developments

11.11 SIBIONO

11.11.1 SIBIONO Company Information

11.11.2 SIBIONO Gene-based Advanced Therapy Medical Product Product Offered

11.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SIBIONO Main Business Overview

11.11.5 SIBIONO Latest Developments

11.12 AnGes

11.12.1 AnGes Company Information

11.12.2 AnGes Gene-based Advanced Therapy Medical Product Product Offered

11.12.3 AnGes Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AnGes Main Business Overview

11.12.5 AnGes Latest Developments

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Information

11.13.2 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

11.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Orchard Therapeutics Main Business Overview

11.13.5 Orchard Therapeutics Latest Developments

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Information

11.14.2 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product Offered

11.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Human Stem Cells Institute Main Business Overview

11.14.5 Human Stem Cells Institute Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Gene-based Advanced Therapy Medical Product Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Viral Gene Delivery System

Table 3. Major Players of Non-viral Gene Delivery System

Table 4. Gene-based Advanced Therapy Medical Product Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

Table 7. Gene-based Advanced Therapy Medical Product Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

Table 10. Global Gene-based Advanced Therapy Medical Product Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Player (2020-2022)

Table 12. Gene-based Advanced Therapy Medical Product Key Players Head office and Products Offered

Table 13. Gene-based Advanced Therapy Medical Product Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Gene-based Advanced Therapy Medical Product Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Regions (2017-2022)

Table 18. Americas Gene-based Advanced Therapy Medical Product Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Gene-based Advanced Therapy Medical Product Market Size Market Share by Country (2017-2022)

Table 20. Americas Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

Table 22. Americas Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

Table 24. APAC Gene-based Advanced Therapy Medical Product Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Gene-based Advanced Therapy Medical Product Market Size Market Share by Region (2017-2022)

Table 26. APAC Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

Table 28. APAC Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

Table 30. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Country (2017-2022)

Table 32. Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

Table 34. Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Gene-based Advanced Therapy Medical Product

Table 43. Key Market Challenges & Risks of Gene-based Advanced Therapy Medical Product

Table 44. Key Industry Trends of Gene-based Advanced Therapy Medical Product

Table 45. Global Gene-based Advanced Therapy Medical Product Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Gene-based Advanced Therapy Medical Product Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Gene-based Advanced Therapy Medical Product Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Gene-based Advanced Therapy Medical Product Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Gene-based Advanced Therapy Medical Product Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Gene-based Advanced Therapy Medical Product Market Size Market Share Forecast by Application (2023-2028)

Table 51. Biogen Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 52. Biogen Gene-based Advanced Therapy Medical Product Product Offered

Table 53. Biogen Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Biogen Main Business

Table 55. Biogen Latest Developments

Table 56. Novartis Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 57. Novartis Gene-based Advanced Therapy Medical Product Product Offered

Table 58. Novartis Main Business

Table 59. Novartis Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Novartis Latest Developments

Table 61. Gilead Sciences Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 62. Gilead Sciences Gene-based Advanced Therapy Medical Product Product Offered

Table 63. Gilead Sciences Main Business

Table 64. Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Gilead Sciences Latest Developments

Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 67. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

Table 68. Sarepta Therapeutics Main Business

Table 69. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Sarepta Therapeutics Latest Developments

Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 72. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product Offered

Table 73. Alnylam Pharmaceuticals Main Business

Table 74. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Alnylam Pharmaceuticals Latest Developments

Table 76. Amgen Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 77. Amgen Gene-based Advanced Therapy Medical Product Product Offered

Table 78. Amgen Main Business

Table 79. Amgen Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Amgen Latest Developments

Table 81. Spark Therapeutics Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 82. Spark Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

Table 83. Spark Therapeutics Main Business

Table 84. Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Spark Therapeutics Latest Developments

Table 86. Akcea Therapeutics Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 87. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

Table 88. Akcea Therapeutics Main Business

Table 89. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Akcea Therapeutics Latest Developments

Table 91. bluebird bio Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 92. bluebird bio Gene-based Advanced Therapy Medical Product Product Offered

Table 93. bluebird bio Main Business

Table 94. bluebird bio Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. bluebird bio Latest Developments

Table 96. Sunway Biotech Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 97. Sunway Biotech Gene-based Advanced Therapy Medical Product Product Offered

Table 98. Sunway Biotech Main Business

Table 99. Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Sunway Biotech Latest Developments

Table 101. SIBIONO Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 102. SIBIONO Gene-based Advanced Therapy Medical Product Product Offered

Table 103. SIBIONO Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. SIBIONO Main Business

Table 105. SIBIONO Latest Developments

Table 106. AnGes Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 107. AnGes Gene-based Advanced Therapy Medical Product Product Offered

Table 108. AnGes Main Business

Table 109. AnGes Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. AnGes Latest Developments

Table 111. Orchard Therapeutics Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 112. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product Offered

Table 113. Orchard Therapeutics Main Business

Table 114. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Orchard Therapeutics Latest Developments

Table 116. Human Stem Cells Institute Details, Company Type, Gene-based Advanced Therapy Medical Product Area Served and Its Competitors

Table 117. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product Offered

Table 118. Human Stem Cells Institute Main Business

Table 119. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Human Stem Cells Institute Latest Developments

List of Figures

Figure 1. Gene-based Advanced Therapy Medical Product Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Type in 2021

Figure 7. Gene-based Advanced Therapy Medical Product in Neurological Diseases

Figure 8. Global Gene-based Advanced Therapy Medical Product Market: Neurological Diseases (2017-2022) & ($ Millions)

Figure 9. Gene-based Advanced Therapy Medical Product in Cancer

Figure 10. Global Gene-based Advanced Therapy Medical Product Market: Cancer (2017-2022) & ($ Millions)

Figure 11. Gene-based Advanced Therapy Medical Product in Other

Figure 12. Global Gene-based Advanced Therapy Medical Product Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Application in 2021

Figure 14. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Player in 2021

Figure 15. Global Gene-based Advanced Therapy Medical Product Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Gene-based Advanced Therapy Medical Product Market Size 2017-2022 ($ Millions)

Figure 17. APAC Gene-based Advanced Therapy Medical Product Market Size 2017-2022 ($ Millions)

Figure 18. Europe Gene-based Advanced Therapy Medical Product Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size 2017-2022 ($ Millions)

Figure 20. Americas Gene-based Advanced Therapy Medical Product Value Market Share by Country in 2021

Figure 21. Americas Gene-based Advanced Therapy Medical Product Consumption Market Share by Type in 2021

Figure 22. Americas Gene-based Advanced Therapy Medical Product Market Size Market Share by Application in 2021

Figure 23. United States Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Gene-based Advanced Therapy Medical Product Market Size Market Share by Region in 2021

Figure 28. APAC Gene-based Advanced Therapy Medical Product Market Size Market Share by Application in 2021

Figure 29. China Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Country in 2021

Figure 36. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Type in 2021

Figure 37. Europe Gene-based Advanced Therapy Medical Product Market Size Market Share by Application in 2021

Figure 38. Germany Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Market Share by Application in 2021

Figure 46. Egypt Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Gene-based Advanced Therapy Medical Product Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 52. APAC Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 53. Europe Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 55. United States Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 56. Canada Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 59. China Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 60. Japan Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 61. Korea Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 63. India Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 64. Australia Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 65. Germany Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 66. France Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 67. UK Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 68. Italy Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 69. Russia Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 70. Spain Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 73. Israel Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Gene-based Advanced Therapy Medical Product Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390